Cleveland Clinic Cancer Advances

Easing Access to Lung Cancer Screening: The Potential Impact of Blood Tests

January 11, 2024 Cleveland Clinic Taussig Cancer Institute
Easing Access to Lung Cancer Screening: The Potential Impact of Blood Tests
Cleveland Clinic Cancer Advances
More Info
Cleveland Clinic Cancer Advances
Easing Access to Lung Cancer Screening: The Potential Impact of Blood Tests
Jan 11, 2024
Cleveland Clinic Taussig Cancer Institute

Peter Mazzone, MD, MPH, pulmonologist and Section Leader for Thoracic Oncology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the development of blood tests to screen for lung cancer. Listen as Dr. Mazzone explains the intricacies of DNA analysis within these tests, offering insights into their potential to detect lung cancer and alleviate barriers to screenings.

Show Notes

Peter Mazzone, MD, MPH, pulmonologist and Section Leader for Thoracic Oncology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the development of blood tests to screen for lung cancer. Listen as Dr. Mazzone explains the intricacies of DNA analysis within these tests, offering insights into their potential to detect lung cancer and alleviate barriers to screenings.